.Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J01F_MacrolidesLincosamidesAndStreptogramins.J01FA11_Miocamycin.Miocamycin

Information

Miocamycin is a macrolide antibiotic related to erythromycin, primarily developed and formerly used in Japan. It exhibits antibacterial activity mainly against Gram-positive bacteria and some Gram-negative cocci. The drug is now rarely used and is not approved or marketed in most countries today.

Pharmacokinetics

Estimated pharmacokinetic parameters for healthy adults based on limited available literature and inferences from related macrolide antibiotics due to lack of directly referenced clinical PK studies.

References

1. Motohiro, T, et al., & Tomita, S (1990). [Effect of rokitamycin on bacterial flora in human feces]. The Japanese journal of antibiotics 43(2) 285–317. PUBMED:https://pubmed.ncbi.nlm.nih.gov/2362352

Revisions

• 06/2025 initial generated model